Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Aquantia Corp. (AQ) on Behalf of Stockholders and Encourages AQ Investors to Contact the Firm

NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Aquantia Corp. (NYSE: AQ) on behalf of stockholders concerning the proposed acquisition of the company by Marvell Technology Group Ltd. (NASDAQ: MRVL).

Click here to participate in the action.

Pursuant to the proposed transaction, announced on May 6, 2019 and valued at $452 million, Aquantia stockholders will receive $13.25 in cash for each share of Aquantia common stock owned.  The investigation focuses on whether Aquantia and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.

If you own Aquantia shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], or telephone at (212) 308-1869, or by filling out this contact form.  There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation.  For additional information concerning our investigation of Aquantia please go to https://bespc.com/aq/.  For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com.  Attorney advertising.  Prior results do not guarantee similar outcomes. 

Contacts
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 308-1869
[email protected]
www.bespc.com

You May Also Be Interested In

• B.Riley Resumes Taboola (TBLA) at Buy
• VIN Foundation Receives Platinum Seal of Transparency from Candid for Eighth Year in a Row
• Midi Health, the Fastest-Growing Virtual Clinic for Perimenopause and Menopause, Raises an Additional $60M in Series B Round - $100M Total Funding to Date - to Transform Women's Healthcare